• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隧道纳米管介导 KRas 转运:诱导肿瘤异质性并改变细胞细胞膜的机械性能。

Tunneling nanotubes mediate KRas transport: Inducing tumor heterogeneity and altering cellular membrane mechanical properties.

机构信息

College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, PR China.

College of Chemistry, Nankai University, Tianjin, 300071, PR China.

出版信息

Acta Biomater. 2024 Sep 1;185:312-322. doi: 10.1016/j.actbio.2024.06.046. Epub 2024 Jul 4.

DOI:10.1016/j.actbio.2024.06.046
PMID:38969079
Abstract

Mutation in oncogene KRas plays a crucial role in the occurrence and progression of numerous malignant tumors. Malignancy involves changes in cell mechanics for extensive cellular deformation during metastatic dissemination. We hypothesize that oncogene KRas mutations are intrinsic to alterations in cellular mechanics that promote malignant tumor generation and progression. Here, we demonstrate the use of optical tweezers coupled with a confocal fluorescence imaging system and gene interference technique to reveal that the mutant KRas protein can be transported between homogeneous and heterogeneous tumor cells by tunneling nanotubes (TNTs), resulting in a significant reduction of membrane tension and acceleration of membrane phospholipid flow in the recipient cells. Simultaneously, the changes in membrane mechanical properties of the tumor cells also enhance the metastatic and invasive ability of the tumors, which further contribute to the deterioration of the tumors. This finding helps to clarify the association between oncogene mutations and changes in the mechanical properties of tumor cells, which provides a theoretical basis for the development of cancer treatment strategies. STATEMENT OF SIGNIFICANCE: Here, we present a laser confocal fluorescence system integrated with optical tweezers to observe the transfer of mutant KRas protein from mutant cells to wild-type cells through TNTs. Malignancy involves changes in cell mechanics for extensive cellular deformation during metastatic dissemination. Our results demonstrate a significant decrease in membrane tension and an increase in membrane phospholipid flow in recipient cells. These alterations in mechanical properties augment the migration and invasive capabilities of tumor cells, contributing to tumor malignancy. Our findings propose that cellular mechanical properties could serve as new markers for tumor development, and targeting membrane tension may hold potential as a therapeutic strategy.

摘要

癌基因 KRas 突变在许多恶性肿瘤的发生和发展中起着至关重要的作用。恶性肿瘤涉及细胞力学的变化,以在转移传播过程中进行广泛的细胞变形。我们假设癌基因 KRas 突变是促进恶性肿瘤发生和发展的细胞力学变化的内在因素。在这里,我们展示了使用光学镊子结合共聚焦荧光成像系统和基因干扰技术,揭示突变 KRas 蛋白可以通过隧道纳米管(TNTs)在同质和异质肿瘤细胞之间运输,导致膜张力显著降低和受纳细胞中膜磷脂流加速。同时,肿瘤细胞的膜力学性质的变化也增强了肿瘤的转移和侵袭能力,这进一步导致了肿瘤的恶化。这一发现有助于阐明癌基因突变与肿瘤细胞力学性质变化之间的联系,为癌症治疗策略的发展提供了理论依据。

意义陈述

在这里,我们提出了一种将光学镊子与激光共聚焦荧光系统集成的方法,用于观察突变 KRas 蛋白通过 TNTs 从突变细胞转移到野生型细胞。恶性肿瘤涉及细胞力学的变化,以在转移传播过程中进行广泛的细胞变形。我们的结果表明,受纳细胞中的膜张力显著降低,膜磷脂流增加。这些力学性质的改变增强了肿瘤细胞的迁移和侵袭能力,导致肿瘤恶性。我们的发现表明,细胞力学性质可以作为肿瘤发展的新标志物,靶向膜张力可能是一种有前途的治疗策略。

相似文献

1
Tunneling nanotubes mediate KRas transport: Inducing tumor heterogeneity and altering cellular membrane mechanical properties.隧道纳米管介导 KRas 转运:诱导肿瘤异质性并改变细胞细胞膜的机械性能。
Acta Biomater. 2024 Sep 1;185:312-322. doi: 10.1016/j.actbio.2024.06.046. Epub 2024 Jul 4.
2
Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells.致癌性KRAS通过隧道纳米管进行细胞间转移在结肠癌细胞中引入细胞内突变异质性。
Cancers (Basel). 2019 Jun 26;11(7):892. doi: 10.3390/cancers11070892.
3
The use of optical trap and microbeam to investigate the mechanical and transport characteristics of tunneling nanotubes in tumor spheroids.利用光镊和微束研究肿瘤球状体中隧道纳米管的力学和运输特性。
J Biophotonics. 2015 Sep;8(9):694-704. doi: 10.1002/jbio.201400039. Epub 2014 Oct 29.
4
H-Ras transfers from B to T cells via tunneling nanotubes.H-Ras 通过隧道纳米管从 B 细胞转移到 T 细胞。
Cell Death Dis. 2013 Jul 18;4(7):e726. doi: 10.1038/cddis.2013.245.
5
High-throughput, single-particle tracking reveals nested membrane domains that dictate KRas diffusion and trafficking.高通量、单颗粒追踪揭示了决定 KRas 扩散和运输的嵌套膜域。
Elife. 2019 Nov 1;8:e46393. doi: 10.7554/eLife.46393.
6
Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.Notch1 基因突变靶向 KRAS G12D 表达的 CD8+细胞,并有助于其白血病转化。
J Biol Chem. 2013 Jun 21;288(25):18219-27. doi: 10.1074/jbc.M113.475376. Epub 2013 May 14.
7
Protein-RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers.蛋白质-RNA 相互作用动力学揭示了致癌 KRAS 驱动的癌症的关键调节因子。
Sci Rep. 2024 Nov 7;14(1):27119. doi: 10.1038/s41598-024-78333-2.
8
Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathway.丹酚酸F通过PI3K/AKT信号通路抑制KRAS依赖的肺癌细胞生长。
Phytomedicine. 2023 Dec;121:155093. doi: 10.1016/j.phymed.2023.155093. Epub 2023 Sep 17.
9
Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRAS protein to cancer-associated fibroblasts.胰腺癌衍生的细胞外囊泡通过将KRAS蛋白传递给癌症相关成纤维细胞来增强化学抗性。
Mol Ther. 2025 Mar 5;33(3):1134-1153. doi: 10.1016/j.ymthe.2025.01.023. Epub 2025 Jan 14.
10
Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells.致癌性KRAS突变赋予结肠癌细胞对蠕动的独特机械转导反应。
Mol Cancer Res. 2025 Feb 6;23(2):128-142. doi: 10.1158/1541-7786.MCR-24-0624.

引用本文的文献

1
Interplay between tunneling nanotubes and Wnt Signaling: Insights into cytoskeletal regulation and therapeutic potential.隧道纳米管与Wnt信号通路之间的相互作用:对细胞骨架调节和治疗潜力的见解。
Biochem Biophys Rep. 2025 May 27;43:102065. doi: 10.1016/j.bbrep.2025.102065. eCollection 2025 Sep.